Gout
MONDO:0005393A condition characterized by painful swelling of the joints, which is caused by deposition of urate crystals.
Also known as: chronic gout, tophaceous disease, tophaceous gout, gout, gouty arthropathy
102 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New gout pill enters first human tests
Disease control ENROLLING_BY_INVITATIONThis early-stage trial is testing a new oral drug called F-02-2-Na in 69 adults with high uric acid levels, with or without gout. The main goal is to check the drug's safety and how the body processes it at different doses. Participants will receive either the drug or a placebo, …
Phase: PHASE1 • Sponsor: Guangdong Hengqin Novagains Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for tough gout: drug combo targets uric acid after other treatments fail
Disease control OngoingThis study tests a new drug called AR882, taken with a standard gout medication (XOI), in 15 people with severe, uncontrolled gout who have already failed uricase therapy. The goal is to see if the combination can lower uric acid levels and shrink painful uric acid crystal deposi…
Phase: PHASE2 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a chatbot tame gout? new trial puts AI diet coach to the test
Disease control OngoingThis trial tests an AI chatbot called Gout Buddy that gives personalized diet advice to people with gout. 110 participants will either use the chatbot or receive standard care. The goal is to see if the chatbot improves dietary knowledge, eating habits, medication adherence, and …
Phase: NA • Sponsor: SingHealth Polyclinics • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New gout drug shows promise in major trial
Disease control OngoingThis study tests a new medicine called AR882 to see if it can lower uric acid levels in people with gout. About 750 adults with gout will receive either AR882 or a placebo for 12 months. The main goal is to see if AR882 helps more patients reach a safe uric acid level and reduce …
Phase: PHASE3 • Sponsor: Arthrosi Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Gout patients in the south get a new tool: storytelling on a tablet
Disease control OngoingThis study tests whether a culturally tailored storytelling video, shown on a tablet, can help 200 gout patients—especially African Americans in the Southeast—better understand their condition and stick with long-term treatments like medication, diet, and exercise. The goal is to…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Digital health program could transform diabetes care for seniors with multiple illnesses
Disease control ENROLLING_BY_INVITATIONThis study tests a 6-month digital care program for adults aged 50+ with type 2 diabetes and at least one other chronic condition like high blood pressure or kidney disease. The program combines online education, phone support, a mobile health app, home visits, and personalized c…
Phase: NA • Sponsor: Chang Gung University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Email your doctor to beat gout: new trial tests remote care
Disease control OngoingThis study tests whether regular email communication between gout patients and their doctors can help lower uric acid levels more effectively than standard care. 204 adults with confirmed gout will either follow usual care or use a secure messaging system to adjust their medicati…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Pharmacists take on heart disease: new study tests community-based risk reduction
Disease control OngoingThis study tests whether a pharmacist-led program can help people reduce their risk of heart disease. Over 1,000 adults with conditions like diabetes, high blood pressure, or obesity are taking part. Pharmacists use a step-by-step guide to assess risk and support lifestyle change…
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New injection aimed at easing gout flares enters early human testing
Symptom relief OngoingThis early-stage study tests a single dose of a new antibody injection in 64 people. Part A includes healthy volunteers to check safety, and Part B includes people with an acute gout flare. The main goal is to see if the drug is safe and how the body processes it.
Phase: PHASE1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
New hope for gout sufferers with kidney problems: safer flare treatment tested
Symptom relief TerminatedThis study tests if anakinra is better than prednisone for treating gout flares in people with advanced chronic kidney disease or who have had a kidney transplant. Gout causes sudden, severe joint pain. Standard treatments can be risky for these patients. The study measures pain …
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
AI-Powered ECG could spot dangerous potassium shifts without blood draws
Knowledge-focused TerminatedThis study planned to use a machine learning algorithm to estimate blood potassium levels from a single-lead ECG in hospitalized patients. It was designed as a retrospective analysis of existing data from a home hospital program. However, the study was withdrawn before enrolling …
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
AI predicts hospital stays, but study never started
Knowledge-focused TerminatedThis study aimed to see if a computer could learn to predict how long a patient would stay in a home hospital program. Researchers planned to use data from past patients to train the computer. However, the study was withdrawn before any patients were enrolled, so no results are a…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Plant protein swap may cut heart & diabetes risk – but how much?
Knowledge-focused OngoingThis study is a review of many smaller trials that looked at what happens when people replace animal protein (like meat, dairy, eggs) with plant protein (like beans, nuts, seeds). The goal is to see if this simple swap can improve blood sugar, cholesterol, blood pressure, weight,…
Sponsor: John Sievenpiper • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Scans may spot gout risk years before first attack
Knowledge-focused OngoingThis study follows 21 people with high uric acid but no gout symptoms for up to 5 years. Researchers use ultrasound and CT scans to look for tiny crystal deposits in joints. The goal is to see if these deposits can predict who will later develop painful gout flares.
Phase: NA • Sponsor: Lille Catholic University • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:09 UTC
-
New CT scan reveals how gout treatments melt crystal deposits
Knowledge-focused OngoingThis study follows 50 adults with tophaceous gout who are starting or adjusting urate-lowering therapy. Researchers use a special CT scan (Dual-Energy CT) to measure how much the uric acid crystals in tophi shrink after 6 and 12 months of treatment. They also check whether bone e…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:46 UTC